# US 11,307,141 B2 · Spatially resolved ligand-receptor binding assays

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,307,141 B2
- Document ID: US11307141B2
- Status: Granted
- Kind: B2
- Application number: 16/237,098
- Filed: 2018-12-31
- Published: 2019-06-27
- Granted: 2022-04-19
- Earliest claimed: 2011-06-06
- Assignees: Abbott Laboratories
- Applicants: Abbott Laboratories
- Inventors: Qiaoqiao Ruan; Sylvia C. Saldana; Joseph P. Skinner; Sergey Y. Tetin
- Web page: https://patentgrep.com/patent/US11307141B2

## CPC

- G01N 21/6456: {Spatial resolved fluorescence measurements; Imaging}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for analyzing the results of a ligand-receptor binding assay comprising the steps of: (a) providing the results of a ligand-receptor binding assay; and (b) qualifying the results of a ligand-receptor binding assay. More particularly, the ligand-receptor binding assay involves the steps of combining appropriate reagents in which receptors attached to a solid support, a sample suspected of containing a ligand, and a conjugate comprising a label form a complex in which the label is present at a concentration that is directly proportional to the amount of ligand present in the sample. Alternatively, the ligand-receptor binding assay involves the steps of combining appropriate reagents to perform a ligand-receptor binding assay in which receptors attached to a solid support, a sample suspected of containing a ligand, and a conjugate comprising a label form a complex in which the label is present at a concentration that is inversely proportional to the amount of analyte present in the sample.

## Claims

### Claim 1

A method for determining the concentration of a ligand in a sample comprising the steps of:
(a) combining in a reaction mixture (i) a sample suspected of containing a ligand, (ii) a first receptor attached to a microparticle that binds to the ligand, and (iii) a fluorescently labeled second receptor that binds to the ligand, and allowing formation of a complex comprising the microparticle attached to the first receptor, the ligand, and the fluorescently labeled second receptor;
(b) acquiring a white light image of the reaction mixture in order to determine the location of the microparticle in the reaction of step (a) and a fluorescence image of the reaction mixture in order to determine the location of the fluorescently labeled second receptor in the reaction of step (a);
(c) selecting at least one region of interest from the images acquired in step (b), wherein the at least one region of interest is a region from which light signals emanate from the complex formed in step (a);
(d) selecting pixels in the at least one region of interest for analysis;
(e) calculating and recording the average and variance of the counts per pixel for the pixels selected in step (d), wherein the counts per pixel is the number of photons counted per pixel per unit of time;
(f) omitting pixels that have counts greater or less than a specified variance;
(g) calculating average counts per pixel of the remaining pixels; and
(h) determining the concentration of the ligand from the data in step (g).

### Claim 2 (depends on 1)

The method of claim 1, wherein the images acquired in step (b) are digital images.

### Claim 3 (depends on 1)

The method of claim 1, wherein only up to about two hundred (200) microparticles are required.

### Claim 4 (depends on 1)

The method of claim 1, wherein the images acquired in step (b) are recorded by a fluorescence microscope equipped with a digital camera.

### Claim 5 (depends on 1)

The method of claim 1, wherein a record of the assay is stored in computer data storage.

### Claim 6 (depends on 1)

The method of claim 1, wherein the images acquired in step (b) are acquired and stored off-line.

### Claim 7 (depends on 1)

The method of claim 1, wherein spatial information is used to qualify and quantify the results of a ligand-receptor binding assay.

### Claim 8 (depends on 1)

The method of claim 1, wherein the ligand is a single stranded nucleic acid sequence, the first receptor is a capture nucleic acid sequence complementary to the single stranded nucleic acid sequence, and the second receptor is a fluorescently labeled nucleic acid sequence that is identical to the single-stranded nucleic acid sequence.

### Claim 9 (depends on 1)

The method of claim 1, wherein the omitted pixels of step (f) have counts greater or less than two times the variance.